Andreas Lundqvist

The solid tumor microenvironment changes the hierarchy of CD155 and CD112 receptors, shaping checkpoint blockade outcome

Valentina Carannante, Karl Olofsson, Hanqing Zhang, Niklas Sandström et autres

se (code pays fourni par la source)

BET Inhibition Synergizes with RLR Signaling to Enhance Tumor Immunogenicity and T-cell Recognition

Lucas Baldran-Groves, Rok Žiberna, Marc-Antoine Gerault, Mireia Cruz De los Santos et autres

se (code pays fourni par la source)

Restoring STING expression in soft tissue sarcoma increases activation and function of tumor-infiltrating lymphocytes

Stine Høvring Godsk, Mireia Crus De los Santos, Tobias Wang Bjerg, Thomas Gravgaard Andersen et autres

dk, se (code pays fourni par la source)

Glucocorticoid prophylaxis influences the systemic immune macroenvironment in patients with early stage, treatment naïve, HER2+ breast cancer

Aine O’Reilly, Ioannis Zerdes, Max Backman, Yago Pico de Coaña et autres

ie, se, us (code pays fourni par la source)

Neutral sphingomyelinases restrict natural killer cells activity against lung cancer

Riccardo Cinotti, Mannon Geindreau, Anna Bergqvist, Ying Yang et autres

se (code pays fourni par la source)

Supplementary Figure 7 and 8 from Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti–PD-1 and Anti–PD-L1 Treatment in a Checkpoint Refractory Melanoma Model

Rosanne E. Veerman, Gözde Güçlüler Akpinar, Annemarijn Offens, Loïc Steiner et autres

Figure 4 from Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti–PD-1 and Anti–PD-L1 Treatment in a Checkpoint Refractory Melanoma Model

Rosanne E. Veerman, Gözde Güçlüler Akpinar, Annemarijn Offens, Loïc Steiner et autres

Figure 1 from Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti–PD-1 and Anti–PD-L1 Treatment in a Checkpoint Refractory Melanoma Model

Rosanne E. Veerman, Gözde Güçlüler Akpinar, Annemarijn Offens, Loïc Steiner et autres

Figure 2 from Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti–PD-1 and Anti–PD-L1 Treatment in a Checkpoint Refractory Melanoma Model

Rosanne E. Veerman, Gözde Güçlüler Akpinar, Annemarijn Offens, Loïc Steiner et autres

Figure 3 from Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti–PD-1 and Anti–PD-L1 Treatment in a Checkpoint Refractory Melanoma Model

Rosanne E. Veerman, Gözde Güçlüler Akpinar, Annemarijn Offens, Loïc Steiner et autres

Supplementary Figure 1 from Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti–PD-1 and Anti–PD-L1 Treatment in a Checkpoint Refractory Melanoma Model

Rosanne E. Veerman, Gözde Güçlüler Akpinar, Annemarijn Offens, Loïc Steiner et autres

Supplementary Figure 2 from Antigen-Loaded Extracellular Vesicles Induce Responsiveness to Anti–PD-1 and Anti–PD-L1 Treatment in a Checkpoint Refractory Melanoma Model

Rosanne E. Veerman, Gözde Güçlüler Akpinar, Annemarijn Offens, Loïc Steiner et autres